Learn more

BEIJING INST OF HEART LUNG AND BLOOD VESSEL DISEASES

Overview
  • Total Patents
    42
  • GoodIP Patent Rank
    40,080
  • Filing trend
    ⇧ 100.0%
About

BEIJING INST OF HEART LUNG AND BLOOD VESSEL DISEASES has a total of 42 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement, pharmaceuticals and biotechnology are FUNDACIÓ HOSPITAL UNI VALL D HEBRON INST DE RECERCA, DIAMANDIS ELEFTHERIOS P and OPEXA THERAPEUTICS INC.

Patent filings in countries

World map showing BEIJING INST OF HEART LUNG AND BLOOD VESSEL DISEASESs patent filings in countries

Patent filings per year

Chart showing BEIJING INST OF HEART LUNG AND BLOOD VESSEL DISEASESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Du Jie 35
#2 Li Yulin 20
#3 Liu Tingting 6
#4 Wang Yuan 6
#5 Piao Chunmei 6
#6 Tan Xin 5
#7 Zheng Shuai 5
#8 Li Fengjuan 4
#9 Qin Yanwen 4
#10 Wang Xue 4

Latest patents

Publication Filing date Title
CN112114152A Application of serum S100A8/A9 complex level in CABG surgery prognosis judgment
CN111184734A Application of miRNA in treatment of myocardial hypertrophy
CN111154866A miRNA marker for predicting complicated myocardial hypertrophy of hypertension patient and application thereof
CN112048549A Application of miRNA in detecting myocardial hypertrophy and obstruction type hypertrophic cardiomyopathy
CN111135303A Application of substance for inhibiting angiopoietin-like protein8
CN110777215A Method for detecting whether C2Z7 type transgenic corn ingredient is contained in food or not by aid of metagenome technology
CN110760607A Method for detecting 52C7 type transgenic corn component in food to be detected
CN110694068A Application of substance for inhibiting angiopoietin-like protein8
CN110824170A Biomarker for predicting adverse event of acute pulmonary embolism patient and application of biomarker
CN110613847A Application of substance for inhibiting angiopoietin-like protein8
CN110514847A Application of the serum LysoPA in Children with Dilated Cardiomyopathy prognosis
CN110272989A Obstructive sleep apnea genetic risk assesses kit and its application
CN111830142A Use of ceramides for the production of a kit for assessing the risk of an adverse event in a heart failure patient
CN110042127A Preparation, preparation method and the application of cells into cardiomyocytes delivering target nucleic acid molecules
CN111100877A Preparation method and application of hypertrophic cardiomyopathy mouse model
CN109283341A The biomarker of the PCI Postoperative determination of one group of prediction myocardial infarction patient
CN108982844A Application of the serum S100a8/9 complex level in Diagnosis of Acute Myocardial Infarction and Index for diagnosis
CN108982871A Application of the serum sST2 in Children with Dilated Cardiomyopathy prognosis
CN108802379A One group of molecular marker group for judging dissection of aorta prognosis
CN108403677A Application of the crocin in preventing and treating Human Thoracic Aortic Dissection/aortic aneurysm